CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Issuance of shares for SWG acquisition	Issuance of common shares for BBI acquisition	Common Stock	Common Stock Issuance of shares for SWG acquisition	Common Stock Issuance of common shares for BBI acquisition	Additional Paid-in Capital	Additional Paid-in Capital Issuance of shares for SWG acquisition	Additional Paid-in Capital Issuance of common shares for BBI acquisition	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning Balance (in shares) at Dec. 31, 2019				18,996,948
Beginning Balance at Dec. 31, 2019	$ 543,658			$ 18,997			$ 409,805			$ 110,460	$ 10,089	$ (5,693)
Treasury stock, beginning balance (in shares) at Dec. 31, 2019												(194,682)
Net income	52,505									52,505
Common stock repurchased (in shares)												(289,302)
Common stock repurchased	(8,067)											$ (8,067)
Other comprehensive income (loss)	15,727										15,727
Issuance of shares for acquisition (in shares)					2,546,967
Issuance of share for acquisition		$ 47,858	$ 0		$ 2,547			$ 45,311
Dividends on common stock	(8,724)									(8,724)
Issuance of restricted stock grants (in shares)				78,189
Issuance restricted stock grant				$ 78			(78)
Restricted stock grants forfeited (in shares)				(7,421)
Restricted stock grant forfeited				$ (7)			7
Compensation expense	2,352						2,352
Repurchase of restricted stock for payment of taxes (in shares)				(15,690)
Repurchase of restricted stock for payment of taxes	(494)			$ (16)			(478)
Ending Balance (in shares) at Dec. 31, 2020				21,598,993
Ending Balance at Dec. 31, 2020	644,815			$ 21,599			456,919			154,241	25,816	$ (13,760)
Treasury stock, ending balance (in shares) at Dec. 31, 2020												(483,984)
Net income	64,167									64,167
Common stock repurchased (in shares)												(165,623)
Common stock repurchased	(5,171)											$ (5,171)
Other comprehensive income (loss)	(17,838)										(17,838)
Issuance of share for acquisition		0	0
Dividends on common stock	(12,180)									(12,180)
Issuance of restricted stock grants (in shares)				93,578
Issuance restricted stock grant				$ 94			(94)
Restricted stock grants forfeited (in shares)				(2,021)
Restricted stock grant forfeited				$ (2)			2
Compensation expense	3,100						3,100
Repurchase of restricted stock for payment of taxes (in shares)				(21,906)
Repurchase of restricted stock for payment of taxes	(721)			$ (22)			(699)
Ending Balance (in shares) at Dec. 31, 2021				21,668,644
Ending Balance at Dec. 31, 2021	676,172			$ 21,669			459,228			206,228	7,978	$ (18,931)
Treasury stock, ending balance (in shares) at Dec. 31, 2021												(649,607)
Net income	62,919									62,919
Common stock repurchased (in shares)												(600,000)
Common stock repurchased	(22,180)											$ (22,180)
Other comprehensive income (loss)	(156,935)										(156,935)
Issuance of shares for acquisition (in shares)						3,498,936
Issuance of share for acquisition		$ 0	$ 101,469			$ 3,499			$ 97,970
Dividends on common stock	(16,524)									(16,524)
Issuance of restricted stock grants (in shares)				129,950
Issuance restricted stock grant				$ 130			(130)
Restricted stock grants forfeited (in shares)				(2,500)
Restricted stock grant forfeited				$ (3)			3
Compensation expense	2,425						2,425
Repurchase of restricted stock for payment of taxes (in shares)				(19,661)
Repurchase of restricted stock for payment of taxes	(683)			$ (20)			(663)
Ending Balance (in shares) at Dec. 31, 2022				25,275,369
Ending Balance at Dec. 31, 2022	$ 646,663			$ 25,275			$ 558,833			$ 252,623	$ (148,957)	$ (41,111)
Treasury stock, ending balance (in shares) at Dec. 31, 2022												(1,249,607)